Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that is both preventable and treatable. Our understanding of the pathophysiology of this complex condition continues to grow and our ability to offer effective treatment to those who suffer from it has improved considerably. The purpose of the present educational initiative of the Canadian Thoracic Society (CTS) is to provide up to date information on new developments in the field so that patients with this condition will receive optimal care that is firmly based on scientific evidence. Since the previous CTS management recommendations were published in 2003, a wealth of new scientific information has become available. The…

• P
  Pfizer
• G
  GlaxoSmithKline
• AC
  AstraZeneca Canada
• AC
  Abbott Canada
• CT
  Canadian Thoracic Society
• PH
  Public Health Agency of Canada
• CL
  Canadian Lung Association
• PH
  Public Health Agency
• BI
  Boehringer Ingelheim Fonds
• AD
  Association des pharmaciens du Canada